Business Context and Reporting Period
This Form 8-K is filed by Eyenovia, Inc. (trading symbol: EYEN) on April 29, 2025. The report addresses a regulatory notice received from the Nasdaq Stock Market regarding the company's continued listing status. The filing is signed by Michael Rowe, Chief Executive Officer, on May 2, 2025.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. The only financial metric disclosed is the company's stockholders' equity, which was reported in the Annual Report on Form 10-K for the year ended December 31, 2024, as being below the Nasdaq minimum requirement of $2,500,000.
Material Changes
The material event reported is the receipt of a notice from Nasdaq staff indicating non-compliance with Listing Rule 5550(b)(1) due to insufficient stockholders' equity. This notice has no immediate effect on the trading of the company's common stock on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
- Compliance Timeline: The company has 45 calendar days (until June 13, 2025) to submit a plan to regain compliance.
- Extension Possibility: If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days (until October 26, 2025) to achieve compliance.
- Appeal Rights: If the plan is not accepted, the company retains the right to appeal to a Hearings Panel.
- Risks: The filing explicitly states there is no assurance that the company will regain compliance, be granted an extension, or avoid delisting. Forward-looking statements regarding these outcomes involve significant uncertainty.
Investor Verification Checklist
- Verify the exact stockholders' equity figure reported in the Form 10-K for the year ended December 31, 2024.
- Monitor the company's submission of a compliance plan by the June 13, 2025 deadline.
- Track any announcements regarding Nasdaq's acceptance of the plan or the granting of an extension.
- Review the company's capital raising activities or strategic actions intended to restore equity levels.